| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111820 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111818 Combinations of Eszopiclone and O-Desmethylvenlafaxine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders |
| 04/30/2009 | US20090111817 Combinations of Eszopiclone and an Antidepressant |
| 04/30/2009 | US20090111816 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | US20090111814 Feminine anti-itch gel |
| 04/30/2009 | US20090111813 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/30/2009 | US20090111812 Methods for treating inflammatory disorders |
| 04/30/2009 | US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111810 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | US20090111809 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111808 Novel histamine h3-receptor ligands and their therapeutic applications |
| 04/30/2009 | US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111805 Bicyclic heteroaromatic derivatives useful as anticancer agents |
| 04/30/2009 | US20090111804 ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2a |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111801 Substituted pyrazinone derivatives for use as a medicine |
| 04/30/2009 | US20090111800 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111798 N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide;hepatitis C viral infections; hepatitis C NS5B polymerase inhibitors; enzyme inhibitors; viricides; side-effect reduction |
| 04/30/2009 | US20090111797 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches |
| 04/30/2009 | US20090111796 7-membered ring compound and method of production and pharmaceutical application thereof |
| 04/30/2009 | US20090111795 Multimers of Heterocyclic Compounds and Their Use |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111793 Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production |
| 04/30/2009 | US20090111792 Injectable capsaicin with tricyclic antidepressant adjunctive agent |
| 04/30/2009 | US20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same |
| 04/30/2009 | US20090111790 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/30/2009 | US20090111788 Antibiotic compositions of modified release and process of production thereof |
| 04/30/2009 | US20090111787 Polymer blends for drug delivery stent matrix with improved thermal stability |
| 04/30/2009 | US20090111786 Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| 04/30/2009 | US20090111785 Combinations comprising antimuscarinic agents and corticosteroids |
| 04/30/2009 | US20090111784 Medication against breast cancer and related diseases |
| 04/30/2009 | US20090111783 Dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin for treating the hyperpigmentation of pathological scars |
| 04/30/2009 | US20090111782 Composition and methods relating to glucocorticoid receptor-alpha and peroxisome proliferator-activated receptors |
| 04/30/2009 | US20090111781 Use of Cymipristone Type Compounds in Aids Treatment |
| 04/30/2009 | US20090111780 Compositions and methods for treatment of ear canal infection and inflammation |
| 04/30/2009 | US20090111779 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111777 Jelly Composition |
| 04/30/2009 | US20090111776 Novel tetracycline derivatives as antibacterial agents |
| 04/30/2009 | US20090111775 Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitates delivery into cells in vivo |
| 04/30/2009 | US20090111774 Pmea lipid conjugates |
| 04/30/2009 | US20090111773 Compositions and methods of using lamellar bodies for modifying linear biological macromolecules |
| 04/30/2009 | US20090111772 Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 04/30/2009 | US20090111771 Inhibition of cathepsin k activity and the treatment and prevention of disease |
| 04/30/2009 | US20090111770 Pharmaceutical Composition Free From Dexpanthenol, Calcium Ions, and Phosphate and Use of Calcium Chelating Agent and Ophthalmologically Compatible Viscosity Regulator |
| 04/30/2009 | US20090111769 Antithrombotic Compound |
| 04/30/2009 | US20090111768 Regulators of protein misfolding and neuroprotection and methods of use |
| 04/30/2009 | US20090111767 Modulation of insulin like growth factor i receptor expression |
| 04/30/2009 | US20090111766 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111764 Mitochondrial selection |
| 04/30/2009 | US20090111763 Loadable polymeric particles for bone augmentation and methods of preparing and using the same |
| 04/30/2009 | US20090111762 Method of diagnosing and treating cancer using b-catenin splice variants |
| 04/30/2009 | US20090111761 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111760 Macrolone compounds |
| 04/30/2009 | US20090111754 Selective Inhibitors of Nuclear Factor KappaB Activation and Uses Thereof |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111742 Use of fgf-21 and thiazolidinedione for treating type 2 diabetes |
| 04/30/2009 | US20090111733 Par-4 related methods and compositions |
| 04/30/2009 | US20090111732 Gelling Hydrophobic Injectable Polymer Compositions |
| 04/30/2009 | US20090111731 Novel topical application agents against mimic and age-related wrinkles |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090110760 Lipometabolism improver containing pine bark extract |
| 04/30/2009 | US20090110755 Compositions and Methods for Preventing Migraines |
| 04/30/2009 | US20090110753 Enzyme-cleavable prodrug compounds |
| 04/30/2009 | US20090110746 New class of therapeutics that enhance small modecule diffusion |
| 04/30/2009 | US20090110745 Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
| 04/30/2009 | US20090110740 Materials and Methods for Modulating Metabolism |
| 04/30/2009 | US20090110739 Targeted cancer chemotherapy using synthetic nanoparticles |
| 04/30/2009 | US20090110737 Orally Disintegrating Powder Comprising Cilostazol and Mannitol |
| 04/30/2009 | US20090110736 Alloplastic injectable dermal filler and methods of use thereof |
| 04/30/2009 | US20090110735 Controlled release formulations |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | US20090110732 Bioresorbable composition for repairing skeletal tissue |
| 04/30/2009 | US20090110731 Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same |
| 04/30/2009 | US20090110729 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 04/30/2009 | US20090110728 Zero-Order Modified Release Solid Dosage Forms |
| 04/30/2009 | US20090110727 Extended release compositions of proton pump inhibitors |
| 04/30/2009 | US20090110724 Compositions and methods for treatment of pain |
| 04/30/2009 | US20090110722 Composition |
| 04/30/2009 | US20090110720 Use of compounds for the prevention of drug-induced cell toxicity |
| 04/30/2009 | US20090110719 Polyamine modified particles |
| 04/30/2009 | US20090110718 Derivatives of tiacumicin B as anti-cancer agents |
| 04/30/2009 | US20090110717 Transmucosal composition |
| 04/30/2009 | US20090110713 Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
| 04/30/2009 | US20090110711 Implantable device having a slow dissolving polymer |
| 04/30/2009 | US20090110709 Composition comprising an effective amount of a polyphenolic compound, in particular, ellagic acid and/or tannic acid, and a peptide for protection against degradation of cutaneous elastic fibers by elastolytic enzymes; for treating aging or damaged skin |
| 04/30/2009 | US20090110694 Anti-Inflammatory Proteins and Improved Vaccines |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110678 Receptor antagonists for treatment of metastatic bone cancer |
| 04/30/2009 | US20090110673 Methods of reducing cell death following hypoxia / reoxygenation |
| 04/30/2009 | US20090110671 Agent for enhanching the production of collagen and it's use |